NCT04994119View on ClinicalTrials.gov

Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

BIA 5-1058

Oral BIA 5-1058 (Zamicastat) 100 mg tablets

DRUG

Warfarin

Oral Warfarin (Coumadin) 5 mg film coated tablets

Trial Locations (1)

14050

PAREXEL International - Early Phase Clinical Unit - Berlin, Berlin

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04994119 - Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics | Biotech Hunter | Biotech Hunter